Novanta (NOVT) Scheduled to Post Quarterly Earnings on Tuesday

Novanta (NASDAQ:NOVTGet Rating) is scheduled to be announcing its earnings results before the market opens on Tuesday, August 9th. Analysts expect the company to announce earnings of $0.72 per share for the quarter. Novanta has set its Q2 guidance at $0.69 to $0.73 EPS and its Q2 2022 guidance at $0.69-$0.73 EPS.Investors that wish to register for the company’s conference call can do so using this link.

Novanta (NASDAQ:NOVTGet Rating) last issued its quarterly earnings results on Tuesday, May 10th. The technology company reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.10. The company had revenue of $204.20 million for the quarter, compared to analyst estimates of $195.96 million. Novanta had a return on equity of 19.41% and a net margin of 7.73%. The company’s revenue for the quarter was up 25.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.58 EPS. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Down 0.9 %

Shares of NOVT opened at $152.87 on Tuesday. The company has a market capitalization of $5.46 billion, a PE ratio of 94.36 and a beta of 1.16. The company has a current ratio of 2.05, a quick ratio of 1.29 and a debt-to-equity ratio of 0.77. The stock’s 50-day moving average price is $126.26 and its two-hundred day moving average price is $131.51. Novanta has a 12 month low of $110.84 and a 12 month high of $184.44.

Institutional Investors Weigh In On Novanta

A number of large investors have recently added to or reduced their stakes in NOVT. Lazard Asset Management LLC grew its position in shares of Novanta by 23.1% during the 1st quarter. Lazard Asset Management LLC now owns 976 shares of the technology company’s stock valued at $138,000 after acquiring an additional 183 shares during the period. Captrust Financial Advisors grew its position in shares of Novanta by 227.3% during the 1st quarter. Captrust Financial Advisors now owns 1,545 shares of the technology company’s stock valued at $220,000 after acquiring an additional 1,073 shares during the period. Raymond James Trust N.A. grew its position in shares of Novanta by 26.5% during the 1st quarter. Raymond James Trust N.A. now owns 1,904 shares of the technology company’s stock valued at $271,000 after acquiring an additional 399 shares during the period. Ensign Peak Advisors Inc bought a new stake in shares of Novanta during the 1st quarter valued at $280,000. Finally, Jane Street Group LLC bought a new stake in shares of Novanta during the 1st quarter valued at $395,000. Institutional investors own 94.10% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently issued reports on NOVT. TheStreet lowered Novanta from a “b-” rating to a “c+” rating in a report on Wednesday, June 1st. William Blair upgraded Novanta from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 11th.

About Novanta

(Get Rating)

Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Further Reading

Earnings History for Novanta (NASDAQ:NOVT)

Want More Great Investing Ideas?

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.